Dendritic cell therapy is an individualised immunological treatment approach. Whether it may be considered depends on the diagnosis, previous treatment and the patient’s medical situation. Scientific evidence varies by tumour type and indication. It does not replace guideline-based oncological treatment. Possible benefits, limitations and risks are assessed individually; treatment success cannot be guaranteed.